Nucleai

Precision medicine with AI and data.

📋 Overview of Nucleai

Founding Year

2018

Estimated Funding

$0000

Size

$0000

Locations

Tel Aviv

Primary Industry

Pharmaceuticals

📙 About Nucleai

Nucleai transforms patient care by integrating advanced pathology, medicine, biology, and AI. Their platform enhances drug development and precision medicine. It accelerates translational research and diagnostics, improving outcomes in drug development.

💰 Recent Investors of Nucleai

Fosun RZ Capital, M Ventures, Investor

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.